1
|
Korda D, Deák PÁ, Kiss G, Gerlei Z, Kóbori L, Görög D, Fehérvári I, Piros L, Máthé Z, Doros A. Management of Portal Hypertension After Liver Transplantation. Transplant Proc 2018; 49:1530-1534. [PMID: 28838434 DOI: 10.1016/j.transproceed.2017.06.015] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
INTRODUCTION Post-transplantation portal hypertension has severe complications, such as esophageal varix bleeding, therapy refractory ascites, extreme splenomegaly, and graft dysfunction. The aim of our study was to analyze the effectiveness of the therapeutic strategies and how to visualize the procedure. METHODS A retrospective study involving liver transplantation patients from the Semmelweis University Department of Transplantation and Surgery was performed between 2005 and 2015. The prevalence, etiology, and leading complications of the condition were determined. The applied interventions' effects on the patients' ascites volume, splenic volume, and the occurrence of variceal bleeding were determined. Mean portal blood flow velocity and congestion index values were calculated using Doppler ultrasonography. RESULTS The prevalence of post-transplantation portal hypertension requiring intervention was 2.8%. The most common etiology of the disease was portal anastomotic stenosis. The most common complications were esophageal varix bleeding and therapy refractory ascites. The patients' ascites volume decreased significantly (2923.3 ± 1893.2 mL vs. 423.3 ± 634.3 mL; P < .05), their splenic volume decreased markedly. After the interventions, only one case of recurrent variceal bleeding was reported. The calculated Doppler parameters were altered in the opposite direction in cases of pre-hepatic versus intra- or post-hepatic portal hypertension. After the interventions, these parameters shifted towards the physiologic ranges. CONCLUSION The interventions performed in our clinic were effective in most cases. The patients' ascites volume, splenic volume, and the prevalence of variceal bleeding decreased after the treatment. Doppler ultrasonography has proved to be a valuable imaging modality in the diagnosis and the follow-up of post-transplantation portal hypertension.
Collapse
Affiliation(s)
- D Korda
- Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary.
| | - P Á Deák
- Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - G Kiss
- Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - Z Gerlei
- Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - L Kóbori
- Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - D Görög
- Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - I Fehérvári
- Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - L Piros
- Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - Z Máthé
- Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - A Doros
- Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| |
Collapse
|
2
|
Gerlei Z, Sárváry E, Lengyel G, Görög D, Fehérvári I, Nemes B, Kóbori L, Langer RM. Measurement and clinical significance of interleukin 28B in hepatitis C virus-infected liver transplant patients. Transplant Proc 2012; 44:2154-6. [PMID: 22974940 DOI: 10.1016/j.transproceed.2012.07.101] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
One-third of the liver transplantations are performed because of hepatitis C cirrhosis all over the world and also in Hungary. The recurrence rate is practically 100%, influencing graft and patient survivals; within 5 years cirrhosis develops again in 20% to 30% of cases. The therapy is pegylated interferon α-2a and α-2b plus ribavirin as for nontransplanted subjects with the goal to eradicate the virus and maintain graft function. In 25% to 45% of treated patients, it is possible to achieve a sustained virological response (SVR). The response is influenced by viral, donor, and recipient factors. We investigated the genotype of 68 liver recipients transplanted because of hepatitis C virus (HCV) infection between September 1998 and February 2011. We focused on the interleukin (IL) 28B gene locus single nucleotide polymorphism found on chromosome 19; the rs12979860 minor allele (homozygous [wild TT and CC], heterozygous [CT]) in relation to the interferon response. Ten percent of the patients belonged to the CC, 62% to the CT, and 28% to the TT group, and 83% of the CC group became negative or therapy is still ongoing. The CT genotype reached 15.4% SVR with ongoing treatment for most patients. In TT carriers showed a 23.5% SVR. Our patients formed a homogenous group regarding the surgical team, the therapy, and the HCV genotype. Ninety percent belonged to the possible "hard to treat" group. The 10% CC group gave the highest number of SVR and HCV polymerase chain reaction negativity upon antiviral therapy. Regarding our results, one has to take in consideration the small patient number and the fact that the cirrhotic patients were listed for transplantation where they could not be treated or became therapy-resistant. IL28B is just one predictive factor among others for successful posttransplant HCV therapy; further examinations are needed to fully understand its role.
Collapse
Affiliation(s)
- Z Gerlei
- Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | | | | | | | | | | | | | | |
Collapse
|
3
|
Abstract
BACKGROUND The first successfully delivered newborn after organ transplantation was reported in 1963; since then, >14,000 women have delivered after transplantation. Patients with an end-stage organ disease develop fertility disturbances. One year after a successful solid organ transplantation with stable graft function, fertile women can give birth to a child from a medical point of view. Pregnant transplant patients do experience a high risk of graft function worsening, a rejection episode, and opportunistic infections. Furthermore, the medical therapy may influence teratogenicity. METHODS Between 1974 and September 1, 2010, 5 Hungarian centers performed 6802 solid organ transplantation and lungs were grafted in Vienna, Austria. The organ distribution was: 5971 kidney, 454 liver, 187 heart, 90 combined pancreas-kidney, 5 combined islet-kidney, and 95 lung transplantation. There were no pregnancies among heart, lung, and pancreas recipients. RESULTS In all, 3.9% of the renal and 14.3% of the fertile liver transplanted women gave birth to children. To wit, 23 kidney recipients delivered 27 healthy children (17 boys and 10 girls). In 4 cases, 2 children were born, twice as twins. Among liver recipients, 8 women delivered 8 healthy babies. There was no hepatitis C or B virus-positive patient among the mothers. There was no graft insufficiency, rejection or birth defect. Transplanted mothers often display toxemia or preeclampsia during pregnancy requiring cesarean section. The relatively higher ratio of liver recipients was perhaps due to the rarer occurrence of extrahepatic organ damage, like diabetic nephropathy or cardiomyopathy, and the reversible nature of hepatorenal or hepatopulmonary syndrome. CONCLUSION Delivery of a child by a transplanted mother carries an high risk, requiring interdisciplinary cooperation. The quality of life of solid organ recipients can be significantly raised by childbirth under appropriate circumstances.
Collapse
Affiliation(s)
- Z Gerlei
- Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | | | | | | | | |
Collapse
|
4
|
Gelley F, Zadori G, Firneisz G, Wagner L, Fehervári I, Gerlei Z, Fazakas J, Papai S, Lengyel G, Sarvary E, Nemes B. Relationship between hepatitis C virus recurrence and de novo diabetes after liver transplantation: the Hungarian experience. Transplant Proc 2011; 43:1281-2. [PMID: 21620111 DOI: 10.1016/j.transproceed.2011.03.065] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
De novo diabetes mellitus is a common complication after liver transplantation. It is strongly associated with hepatitis C virus (HCV) infection. We analyzed the relationship between HCV recurrence and de novo diabetes among the Hungarian liver transplant population. This retrospective study included cases from 1995 to 2009 on 310 whole liver transplantations. De novo diabetes was defined if the patient had a fasting plasma glucose ≥126 mg/dL permanently after the third month post liver transplantation, and/or required sustained antidiabetic therapy. De novo diabetes occured in 63 patients (20%). The cumulative patient survival rates at 1, 3, 5, and 8 years were 95%, 91%, 88%, and 88% in the control group, and 87%, 79%, 79%, and 64% in the de novo group, respectively (P=.011). The majority of the patients in the de novo group were HCV positive (66% vs 23%). Early virus recurrence within 5 months was associated with the development of diabetes (80% vs 20% non-diabetic controls; P=.017). The fibrosis (2.05 ± 1.5 vs 1 ± 1; P=.039) and Knodell scores (3.25 ± 2 vs 1.69 ± 1.2; P=.019) were higher among the de novo group after antiviral therapy. Rapid recurrence, more severe viremia, and fibrosis showed significant roles in the developement of de novo diabetes after liver transplantation.
Collapse
Affiliation(s)
- F Gelley
- Departure of Transplantation and Surgery, Semmelweis University Budapest, Hungary.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Kelen K, Ferenczi D, Jankovics I, Varga M, Molnar M, Sallay P, Reusz G, Langer R, Pasti K, Gerlei Z, Szabo A. H1N1 Vaccination in Pediatric Renal Transplant Patients. Transplant Proc 2011; 43:1244-6. [DOI: 10.1016/j.transproceed.2011.03.072] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
6
|
|
7
|
Doros A, Nemes B, Máthé Z, Németh A, Hartmann E, Deák ÁP, Lénárd ZF, Görög D, Fehérvári I, Gerlei Z, Fazakas J, Tóth S, Kóbori L. Treatment of early hepatic artery complications after adult liver transplantation: A single center experience. Interv Med Appl Sci 2010. [DOI: 10.1556/imas.2.2010.4.3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
AbstractIntroductionHepatic artery complication represents recognized sequel of liver transplantation that carries significant morbidity and mortality. Besides retransplantation, hepatic artery recanalization is provided surgically, or by percutaneous angioplasty and stent placement. This study provides an analysis of a single center experience comparing surgical and interventional treatments in cases of early hepatic artery complications.MethodsIn this retrospective single center study, 25 of 365 liver transplant recipients were enrolled who developed early hepatic artery complication after transplantation. Percutaneous intervention was performed in 10 cases, while surgical therapy in 15 cases. Mean follow-up time was not different between the groups (505±377 vs. 706±940 days, respectively).Results6 patients in the Intervention Group and 10 patients in the Surgery Group are alive. The retransplantation rate (1 and 3) was lower after interventional procedures, while the development of biliary complications was higher. The mortality rate was higher after operative treatment (2 and 5).ConclusionInterventional therapy is a feasible and safe technique for treatment of early hepatic artery complication after transplantation. Being less invasive it is an invaluable alternative treatment having results comparable to surgical methods.
Collapse
Affiliation(s)
- A. Doros
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
- 2 Department of Transplantation and Surgery, Semmelweis University, Baross u. 23, H-1082, Budapest, Hungary
| | - B. Nemes
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - Z. Máthé
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - A. Németh
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - E. Hartmann
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - Á. P. Deák
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - Zs. F. Lénárd
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - D. Görög
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - I. Fehérvári
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - Zs. Gerlei
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - J. Fazakas
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - Sz. Tóth
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - L. Kóbori
- 1 Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| |
Collapse
|
8
|
Fehervari I, Fazakas J, Gerlei Z, Nemes B, Kobori L. Mitigation of Cytokine Storm by Intraoperative Use of Renal Replacement Therapy During Combined Liver-Kidney Transplantation. Transplant Proc 2010; 42:2353-6. [DOI: 10.1016/j.transproceed.2010.05.142] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
9
|
Sárváry E, Gerlei Z, Dinya E, Tóth E, Varga M, Chmel R, Molnar M, Remport A, Nemes B, Kobori L, Görög D, Fazakas J, Gaal I, Járay J, Perner F, Langer R. Hepatitis C infected hemodialysis and renal transplant patients with elevated α-glutathione S-transferase have increased risk for liver damage. Interv Med Appl Sci 2010. [DOI: 10.1556/imas.2.2010.2.5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
AbstractPatients on hemodialysis (HD) and renal transplant recipients (RT) have a high prevalence of HCV infection. Theaimof our study was to determine the prevalence of HCV-RNA in the anti-HCV positive patients and to compare the biochemical parameters of PCR(+) and PCR(−) subgroups.Methods:The 525 sera were screened for anti-HCV. HCV-RNA was detected by polymerase chain reaction (PCR) and liver enzymes [SGOT, SGPT, GGT,α-glutathione S-transferase (GST)] were measured.Results:Active viraemia was found only in 187 of 289 (65%) seropositive HD patients in contrast to 53 of 53 (100%) of seropositive RT patients. Significantly increased (p<0.05) GST values (9.9 μg/l) were found in the PCR(+) subgroups compared to GST levels (2.7 μg/l) of the PCR(−) subgroups. Elevated GST concentration was found in 80% (208/251) of PCR(+) patients. The measured enzymes were not elevated in HCV infected patients. Six percent of HD and 11% of RT patients were screened before seroconversion. Diagnostic sensitivity (80%) and specificity (79%) of GST were calculated as good for early liver damage caused by HCV. In contrast, the sensitivity of the measurement of other liver enzymes were very weak (SGOT: 8%; SGPT: 10%; GGT: 42%).Conclusion:The significantly higher viraemia of the RT subgroup could be related to the immunosuppressive therapy. Increased GST level may be a useful indicator of tissue damage during HCV infection. If HCV infection is suspected, PCR and GST measurement should be performed, even if anti-HCV result is negative.
Collapse
Affiliation(s)
- Enikő Sárváry
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
- 4 Transplantation and Surgical Clinic, Semmelweis University, Baross u. 23–25, H-1082, Budapest, Hungary
| | - Zs. Gerlei
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - E. Dinya
- 2 EGIS Pharmacenticals LTD., Budapest, Hungary
| | - E. Tóth
- 3 EUROCARE Dialysis Center, Békéscsaba, Hungary
| | - M. Varga
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - R. Chmel
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - M. Molnar
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - A. Remport
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - B. Nemes
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - L. Kobori
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - D. Görög
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - J. Fazakas
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - I. Gaal
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - J. Járay
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - F. Perner
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| | - R. Langer
- 1 Semmelweis University Transplantation and Surgical Clinic, Budapest, Hungary
| |
Collapse
|
10
|
Sarvary E, Lee D, Varadi J, Varga M, Gaal I, Chmel R, Beko G, Kanyo Z, Nemes B, Gerlei Z, Fazakas J, Kobori L, Herold Z, Németh S, Galoczi I, Jaray J, Langer R. The iQ200 Microscopic Analyzer is valuable tool for evaluation of urinary sediment at transplanted patients. Interv Med Appl Sci 2010. [DOI: 10.1556/imas.2.2010.1.5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Abstract
The value of urinary cytology in the diagnosis of different pathological conditions in renal transplantation is particularly important. Manual microscopic urinalysis is a high-volume procedure that currently requires significant labour.
Objective: To automate the sediment evaluation and to make this more accurate using the Iris Diagnostics Automated Urine Microscopy Analyzer (iQ200). Our goal was to compare the manual and automated microscopic data to apply iQ200 in renal function monitoring.
Method: The iQ200 uses digital imaging and Auto Analyte Recognition software to classify urine constituents into 12 analyte categories and quantitatively report.
Results: We determined cut-off values of urine particles in every category, which correlated well with manual microscopic results. The iQ200 was more sensitive for pathological casts than manual microscopic analysis. iQ200 helped the operator to differentiate between isomorphic and dismorphic erythrocytes and between lymphocytes and granulocytes, too. Every pathological constituent could be recognized, which is very important for early recognition of renal impairment, graft rejection and urinary tract infection.
Conclusions: The iQ200 system automatically classifies 12 particles, significantly reducing the need for additional sample preparation, manual microscopic review achieving a high degree of standardization in urinalysis.
Collapse
Affiliation(s)
- Eniko Sarvary
- 1 Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary
- 4 Transplantation and Surgical Clinic, Semmelweis University, Baross u. 23–25, H-1082, Budapest, Hungary
| | - D. Lee
- 2 Diagnosticum Zrt, Budapest, Hungary
| | - J. Varadi
- 2 Diagnosticum Zrt, Budapest, Hungary
| | - M. Varga
- 1 Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary
| | - I. Gaal
- 1 Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary
| | - R. Chmel
- 1 Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary
| | - G. Beko
- 3 I. Department of Medicine, Semmelweis University, Budapest, Hungary
| | - Z. Kanyo
- 2 Diagnosticum Zrt, Budapest, Hungary
| | - B. Nemes
- 1 Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary
| | - Zs. Gerlei
- 1 Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary
| | | | - L. Kobori
- 1 Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary
| | - Zs. Herold
- 1 Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary
| | - S. Németh
- 1 Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary
| | | | - J. Jaray
- 1 Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary
| | - R. Langer
- 1 Transplantation and Surgical Clinic, Semmelweis University, Budapest, Hungary
| |
Collapse
|
11
|
Hartmann E, Németh A, Juharosi G, Lénárd Z, Deák PÁ, Kozma V, Nagy P, Gerlei Z, Fehérvári I, Nemes B, Görög D, Fazakas J, Kóbori L, Doros A. Downstaging of hepatocellular carcinoma with radiofrequency ablation on the Hungarian liver transplantation waiting list — Early results and learned lessons. Interv Med Appl Sci 2009. [DOI: 10.1556/imas.1.2009.1.6] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
Abstract
Hepatocellular carcinoma, which has developed in liver cirrhosis is a disease where liver transplantation can provide a cure both for the tumour and the underlying liver damage. However, patients can only be transplanted when the tumour number and size do not exceed the Milan criteria. Tumour ablation methods — such as radiofrequency ablation — can provide a chance to make the patient eligible for transplantation. Among the 416 Hungarian liver transplanted patients there are 6 who had received different types of ablative therapy as bridging therapy in different institutions. On the basis of analysis of the patients' data we created a guideline for the treatment of cirrhotic patients with hepatocellular carcinoma with the aim of developing a uniform Hungarian approach.
Collapse
Affiliation(s)
- E. Hartmann
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
- 2 Baross u. 23–25, H-1082, Budapest, Hungary
| | - A. Németh
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - Gy. Juharosi
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - Zs. Lénárd
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - P. Á. Deák
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - V. Kozma
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - P. Nagy
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - Zs. Gerlei
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - I. Fehérvári
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - B. Nemes
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - D. Görög
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - J. Fazakas
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - L. Kóbori
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| | - A. Doros
- 1 Clinic for Transplantation and Surgery, Semmelweis University, Budapest, Hungary
| |
Collapse
|
12
|
Reményi P, Gerlei Z, Masszi T. O41 What is the best treatment strategy for Budd-Chiari patients with JAK2 mutation? Blood Rev 2007. [DOI: 10.1016/s0268-960x(07)70058-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
13
|
Nemes B, Sárváry E, Sótonyi P, Gerlei Z, Doros A, Gálffy Z, Fehérvári I, Fazakas J, Járay J, Kóbori L. Factors in association with sepsis after liver transplantation: the Hungarian experience. Transplant Proc 2005; 37:2227-8. [PMID: 15964385 DOI: 10.1016/j.transproceed.2005.03.067] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2005] [Indexed: 11/25/2022]
Abstract
Sepsis is the major cause of patient death after orthotopic liver transplantation (OLT). To identify risk factors for sepsis, we analyzed all 199 primary OLTs performed between 1995 and 2004. Patients were divided into 2 groups according to whether they experienced sepsis after liver transplantation. Recipient, perioperative factors, and complications were subjected to univariate analyses. Statistically significant factors were exposed to multivariate analyses: Cox regression and Hosmer-Lemeshow test. Sepsis occurred in 45 (23%) patients. Recipient Child-Pugh score, preoperative broad spectrum antibiotic (meropenem) prophylaxis, intraoperative red blood cell transfusion, starch infusion, postoperative bleeding, hepatic artery thrombosis, and biliary leakage/necrosis were independent risk factors for sepsis. Our results agree with the international experience. A high amount of starch infusion and an extended use of broad spectrum antibiotics for prophylaxis adverse experiences in our center and have been removed from the protocol.
Collapse
Affiliation(s)
- B Nemes
- Transplantation and Surgical Clinic, Semmelweis University Budapest, Baross u.23, Budapest H-1087, Hungary.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Varga M, Remport A, Hídvégi M, Péter A, Kóbori L, Telkes G, Fazakas J, Gerlei Z, Sárváry E, Sulyok B, Járay J. Comparing cytomegalovirus prophylaxis in renal transplantation: single center experience. Transpl Infect Dis 2005; 7:63-7. [PMID: 16150092 DOI: 10.1111/j.1399-3062.2005.00094.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
BACKGROUND Cytomegalovirus (CMV) presents a serious threat to CMV-seronegative recipients (R-), who have received an organ from a seropositive donor (D+). OBJECTIVES We compared the effectiveness of three different prophylactic protocols in CMV D+/R- patients and reviewed data on patients who received no prophylaxis. PATIENTS AND METHODS We reviewed 1137 kidney transplantations from 1995 to 2004. Of these, 147 recipients were CMV negative (D+/R-); 125 patients received CMV prophylaxis. Group I received CMV hyperimmune gammaglobulin only, group II received CMV hyperimmune gammaglobulin plus oral ganciclovir, and group III received prophylaxis with oral ganciclovir only. RESULTS In group I, CMV infection was observed in 31 of 53 patients (59%), and CMV disease was diagnosed in 9 (17%) during the prophylaxis. In the first year post transplant, a total of 41 of 53 patients (77.5%) had primary CMV infection. In group II, CMV infection occurred in 7 of 30 patients (23%), and CMV disease was diagnosed in only 2 (7%) during prophylaxis. In the first year post transplant, a total of 9 of 30 patients (30%) had primary CMV infection. In group III, 9 of 42 patients (21%) developed CMV infection during prophylaxis, and CMV disease was not observed. In the first year post transplant, a total of 13 of 42 patients (30%) had primary CMV infection. In contrast, all 22 CMV D+/R- patients without prophylaxis developed CMV infection (100%); CMV disease was diagnosed in 10 (45%), and 1 patient died. CONCLUSIONS Prophylaxis with hyperimmune gammaglobulin and/or oral ganciclovir significantly reduces CMV infection and disease. Prophylaxis with ganciclovir was significantly more effective than hyperimmune gammaglobulin monoprophylaxis, and more cost effective than combined prophylaxis.
Collapse
Affiliation(s)
- M Varga
- Transplantation and Surgical Clinic, Faculty of General Medicine, Semmelweis University, Budapest, Hungary.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Kóbori L, Fazakas J, Dallos G, Németh T, Nemes B, Fehérvári I, Gerlei Z, Németh A, Doros A, Slooff MJ, Járay J, De Jong KP. THE USE OF AUTOLOGOUS RECTUS FASCIA SHEATH FOR REPLACEMENT OF INFERIOR CAVAL VEIN DEFECTS IN ORTHOTOPIC LIVER TRANSPLANTATION. Transplantation 2004. [DOI: 10.1097/00007890-200407271-01091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
16
|
Galffy Z, Zala J, Gerlei Z, Jakics J, Perner F. INVESTIGATIONS OF FUNGAL INFECTIONS AMONG LIVER AND KIDNEY TRANSPLANTED PATIENTS. Mycoses 2002. [DOI: 10.1111/j.1439-0507.2002.tb04602.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|